DivcoWest Welcomes Cerevel Therapeutics to Cambridge Crossing

Cambridge, MA, (Aug 07, 2019) – DivcoWest announced today that it has signed a 59,865 square-foot lease with Cerevel Therapeutics at Cambridge Crossing (CX), the new and connected neighborhood at the intersection of Cambridge, Somerville, and Boston. Dedicated to bringing cutting-edge solutions to individuals impacted by nervous system diseases, the bio-pharmaceutical company will join Philips North America at 222 Jacobs Street in 2020, making it the third fully leased commercial building at CX.

READ PRESS RELEASE

Events

Learn more about our events on our Facebook page

News

  • Pfizer spinoff Cerevel moving into Cambridge Crossing

    Boston Globe //
    Read More

  • Renowned Local Chef Will Gilson to Introduce Multi-Concept Restaurant to Cambridge Crossing

    Cambridge Crossing //
    Read More

  • City of Cambridge, in Partnership with DivcoWest, Renames Two Streets in Honor of Prominent Historical Women

    Cambridge Crossing //
    Read More

  • Cambridge honors two in the struggle for equality.

    Boston Globe //
    SEE ARTICLE

  • To stay competitive, developers and landlords are being driven to add telecommunications infrastructure and sophisticated building technology

    New York Times //
    SEE ARTICLE

  • CX Honored with CBA’s Life Science Deal of the Year Award

    Cambridge Crossing //
    Read More

  • Henri Matisse’s grandson inspired these Cambridge musical fences

    Boston.com // 02.26.19
    SEE ARTICLE

  • Local Artist Brings Interactive Art & Sound Sculpture to Cambridge Crossing

    Cambridge Crossing // 02.06.19
    READ PRESS RELEASE

  • Sanofi signs megalease at Cambridge Crossing

    Boston Globe // 12.17.18
    SEE ARTICLE

  • Cambridge Crossing developer aims for top web-connectivity rating

    Boston Business Journal // 11.02.18
    SEE ARTICLE